in new markets - Fresenius Medical Care

for further growth - Fresenius Kabi

for better health - Fresenius Helios

for greater efficiency - Fresenius Vamed

Seizing opportunities > in new markets

Asia is an important growth market for Fresenius Medical Care. Approximately 620,000 patients with chronic kidney failure are currently being treated in this region, and every year this number increases by about 10 to 11%. We will continue to take advantage of this growth potential. The significant demand for dialysis services offers substantial opportunities to expand our network of clinics in the Asian countries.

In 2008, Fresenius Medical Care achieved sales of US$ 606 million in the Asia-Pacific region. Our goal is to continue our strong organic growth and to increase sales to more than US$ 800 million in constant currency by 2010.

FRESENIUS MEDICAL CARE IN ASIA
	2008	2007	Change
Sales (in million US$)	606	541	12%
Employees (December 31)	3,558	3,095	15%
Dialysis patients (December 31)	9,158	7,789	18%
Dialysis treatments (million)	1.34	1.21	11%
Dialysis clinics (December 31)	125	105	19%

in new markets - Fresenius Medical Care

Seizing opportunities > for further growth

With the acquisition of APP Pharmaceuticals, Fresenius Kabi has achieved a leading position in the global market for intravenously administered generic drugs. APP Pharmaceuticals has a strong drug registration portfolio pending and over 70 products under development, opening up new growth opportunities.

At the same time, we are seizing the opportunity of introducing selected Kabi products into the US, with initial focus on parenteral nutrition. We are also planning to launch selected APP IV drugs outside the US.

APP PHARMACEUTICALS IN FIGURES
	2008
Sales	US$ 777 million
EBITDA, adjusted*	US$ 317 million
EBITDA margin, adjusted*	40.8%
Employees (December 31, full-time equivalent)	1,487
Production facilities	3
Produkte	>100
Number of products	~17%

Seizing opportunities > for better health

At Fresenius Helios, our commitment is to provide the highest medical quality and care. We aim to offer advanced and proven best-in-class diagnosis and treatment methods for the benefit of our patients. We continuously invest in high-quality, state-of-the-art medicine, and aim to measure and improve the quality of medical care.

Our target ist that our quality indicators should be better than the German average. With a mortality rate of SMR < 1, this was accomplished, among others, for major illnesses shown below.

HELIOS QUALITY INDICATORS
Indications/ standardized mortality rate (SMR)*	2008 SMR	2007 SMR
Acute myocardial infarction	0.73	0.79
Heart failure	0.73	0.85
Stroke	0.83	1.01
Acute cerebral infarction	0.81	0.99
Pneumonia	0.71	0.85

Seizing opportunities > for greater efficiency

Fresenius Vamed is a leading international provider of services in the planning, construction, and management of health care facilities. Our complete value chain and our more than 25 years of international experience are key to providing effective support for hospitals at every stage of their life cycle, and thus contributing towards their successful operating performance. For us, each project is another opportunity to prove our competence.

Hospitals face the dual challenge of increasing efficiency and reducing expenditure. We support hospitals by offering comprehensive process know-how and by taking over medical-technical services and management functions.

VAMED SERVICES

Service contracts* for	140 clinics
	~ 50,000 beds
among others:
Vienna General Hospital and University Clinics (AKH)	~ 2,100 beds
Charité Hospital Berlin	~ 3,200 beds
University Clinic Hamburg-Eppendorf	~1,370 beds
Prince Court Medical Center, Kuala Lumpur	~ 330 beds
Al Ain Hospital, Abu Dhabi	~ 450 beds

SUPERVISORY BOARD

Dr. Gerd Krick

Königstein

Former Chairman of the Management Board of Fresenius SE

Chairman

Member of the Audit Committee Chairman of the Nomination Committee Chairman of the Personnel Committee

Offices
Supervisory Board
Allianz Private Krankenversicherungs-AG (until April 16, 2008) Fresenius Medical Care AG & Co. KGaA (Chairman) Fresenius Medical Care Management AG VAMED AG, Austria (Chairman)

Advisory Board
HDI Haftpflichtverband der deutschen Industrie V.a.G. (until December 31, 2008)

Prof. Dr. h. c. Roland Berger

(since May 21, 2008)

Munich

Management Consultant

Chairman of the Audit Committee
(since May 21, 2008)

Offices
Supervisory Board
HELIOS Kliniken GmbH
(until April 30, 2008)
Indatex Services for Finance and Insurance AG
(until April 8, 2008)
Live Holding AG
(since June 4, 2008; Deputy Chairman)
Prime Office AG (Chairman)
Roland Berger Strategy Consultants Holding GmbH
(Chairman)
Schuler AG
Senator Entertainment AG
Wilhelm von Finck AG
(Deputy Chairman)
WMP EuroCom AG (Chairman)

Administrative Board
Wittelsbacher Ausgleichs-
fonds

Board of Directors
Fiat S.p.A., Italy
Roland Berger AG, Switzerland (Chairman)
Special Purpose Acquisition Company (SPAC) Germany 1
Acquisition Limited, Guernsey (since July 21, 2008;
Co-Chairman)
Telecom Italia S.p.A., Italy (since April 14, 2008)

Dario Anselmo Ilossi

Rome, Italy

Trade Union Officer FEMCA Cisl –

Energy, Fashion and Chemicals

Konrad Kölbl

Hof am Laithagebirge,
Austria

Full-time Works Council member

Member of the Manual Workers’ Works
Council VAMED-KMB Krankenhausmanagement
und Betriebsführungsges. m.b.H.

Chairman of the Group Works Council VAMED AG

Member of the SE-Works Council of Fresenius SE

Member of the Audit Committee

Corporate Offices
Supervisory Board
VAMED-KMB Krankenhausmanagement und
Betriebsführungsges. m.b.H., Austria

Dr. Gabriele Kröner

(until May 21, 2008)

Berg

Doctor

Klaus-Peter Müller

(since May 21, 2008)

Bad Homburg v.d.H.

Chairman of the Supervisory Board of Commerzbank AG

Offices
Supervisory Board
Commerzbank AG
(since May 15, 2008; Chairman)
Eurohypo AG
(until November 11, 2008; Chairman)
Fraport AG
(since May 28, 2008)
Linde AG
Steigenberger Hotels AG

Administrative Board
Assicurazioni Generali S.p.A., Italy
Commerzbank International S.A., Luxembourg
(until April 9, 2008; President)
KfW Kreditanstalt für Wiederaufbau
Liquiditäts-Konsortialbank GmbH

Board of Directors
Parker Hannifin Corporation, USA

Dr. Gerhard Rupprecht

Gerlingen

Member of the Management Board Allianz SE

Chairman of the Management Board
Allianz Deutschland AG

Offices
Supervisory Board
Allianz Beratungs- und Vertriebs-AG (Chairman)
Allianz Elementar Versicherungs-AG (since February 7, 2008;
Chairman since March 3, 2008)
Allianz Elementar Lebensversicherungs-AG
(since February 7, 2008; Chairman since March 3, 2008)
Allianz First Life Insurance Co. Ltd., Korea
(until December 31, 2007)
Allianz Investmentbank AG (since February 7, 2008;
Deputy Chairman since March 3, 2008)
Allianz Lebensversicherungs-AG (Chairman)
Allianz Private Krankenversicherungs-AG (Chairman)
Allianz Suisse Lebensversicherungs-AG, Switzerland
(since January 1, 2008)
Allianz Suisse Versicherungs-AG, Switzerland
(since January 1, 2008)
Allianz Versicherungs-AG (Chairman)
Heidelberger Druckmaschinen AG

Wilhelm Sachs

Friedrichsdorf

Full-time Works Council member

Deputy Chairman of the Works Council
Friedberg plant

Member of the Joint Works Council Fresenius SE/Friedberg plant

Chairman of the General Works Council Fresenius SE

Member of the SE-Works Council of Fresenius SE

Member of the Personnel Committee

1 of 2
- 1 2

1 of 2
- 1 2